T1	CHEM 98 110	Upadacitinib
T2	LIVB 114 129	sujetos adultos
T3	Age 122 129	adultos
T4	DISO 134 152	dermatitis atópica
#1	AnnotatorNotes T4	C0011615; Dermatitis, Atopic; Disease or Syndrome
T5	PROC 195 260	Estudio de fase 3b/4, aleatorizado, doble ciego y dosis flexibles
T6	Dose 245 260	dosis flexibles
T7	CHEM 264 276	upadacitinib
T8	LIVB 280 287	adultos
#2	AnnotatorNotes T8	C0001675; Adult; Age Group
T9	Age 280 287	adultos
T10	DISO 292 310	dermatitis atópica
#3	AnnotatorNotes T10	C0011615; Dermatitis, Atopic; Disease or Syndrome
T11	DISO 363 381	Dermatitis atópica
#4	AnnotatorNotes T11	C0011615; Dermatitis, Atopic; Disease or Syndrome
T12	LIVB 430 460	Sujetos masculinos o femeninos
T13	Age 461 477	≥ 18 y > 65 años
T14	LIVB 488 495	Sujetos
#5	AnnotatorNotes T14	C0681850; Study Subject; Group
T15	DISO 517 525	síntomas
#6	AnnotatorNotes T15	C1457887; Symptoms; Sign or Symptom
T16	Duration 538 553	al menos 3 años
T17	PROC 643 664	tratamiento sistémico
#7	AnnotatorNotes T17	Systemic Therapy C1515119
T18	PROC 697 718	tratamiento sistémico
T19	DISO 727 729	DA
T20	CHEM 788 804	inhibidor de JAK
T21	Neg_cue 807 809	No
T22	Negated 810 815	poder
T23	Neg_cue 818 820	no
T24	PROC 828 856	interrumpir los tratamientos
T25	Negated 828 856	interrumpir los tratamientos
T26	DISO 876 878	EA
#8	AnnotatorNotes T26	C0002395; Alzheimer's Disease; Disease or Syndrome | C0003507; Aortic Valve Stenosis; Disease or Syndrome | C0038013; Ankylosing spondylitis; Disease or Syndrome | C0947926; Alzheimer's disease (incl subtypes); Mental or Behavioral Dysfunction
T27	CHEM 912 924	medicamentos
#9	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	Contraindicated 912 924	medicamentos
T29	PROC 947 958	tratamiento
#10	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	Spec_cue 1027 1035	pensando
T31	PHYS 1048 1058	embarazada
#11	AnnotatorNotes T31	C0032961; Pregnancy; Organism Function
T32	Speculated 1048 1058	embarazada
T33	PHYS 1006 1015	lactancia
#12	AnnotatorNotes T33	Lactation C0022925
T34	DISO 500 510	DA crónica
#13	AnnotatorNotes T34	Atopic dermatitis, chronic (MTHU003868) / Dermatitis, Atopic C0011615
T35	LIVB 974 990	Mujer embarazada
T36	PROC 46 94	Estudio para evaluar la flexibilidad de la dosis
T37	Route 655 664	sistémico
T38	Route 709 718	sistémico
T39	Quantifier_or_Qualifier 156 172	moderada a grave
T40	Quantifier_or_Qualifier 311 329	moderada o intensa
T41	Quantifier_or_Qualifier 385 401	moderada a grave
T42	CONC 564 577	momento basal
T43	Observation 810 815	poder
T44	Observation 821 827	querer
T45	Observation 1027 1058	pensando en quedarse embarazada
T46	Patient 114 129	sujetos adultos
T47	Patient 280 287	adultos
T48	Patient 430 460	Sujetos masculinos o femeninos
T49	Patient 488 495	Sujetos
T50	Future 643 664	tratamiento sistémico
T51	History_of 697 718	tratamiento sistémico
T52	History_of 788 804	inhibidor de JAK
T53	Patient 974 1015	Mujer embarazada, en periodo de lactancia
T54	Future 1048 1058	embarazada
